首页 | 本学科首页   官方微博 | 高级检索  
     


Effect of indoleamine dioxygenase-1 deficiency and kynurenine pathway inhibition on murine cerebral malaria
Authors:Jenny Miu  Helen J. Ball  Nicholas H. Hunt
Affiliation:a Molecular Immunopathology Unit, Bosch Institute and School of Medical Sciences, Medical Foundation Building (K25), University of Sydney, Sydney, NSW 2006, Australia
b Institute of Molecular Medicine and Genetics, Medical College of Georgia, CA, USA
Abstract:Cerebral malaria (CM) can be a fatal manifestation of Plasmodium falciparum infection. In this study, two different approaches were used to examine the role of indoleamine 2,3-dioxygenase-1 (IDO-1) and its metabolites in the development of murine CM. Mice genetically deficient in IDO-1 were not protected against CM, but partial protection was observed in C57BL/6 mice treated with Ro 61-8048, an inhibitor of kynurenine-3-hydroxylase. This protection was associated with suppressed levels of picolinic acid (PA) within the brain, but not with changes in the levels of kynurenic acid (KA) or quinolinic acid (QA). These data suggest that although IDO-1 is not directly involved in the pathogenesis of CM in C57BL/6 mice, the production of the kynurenine pathway metabolite PA may contribute to the development of murine CM.
Keywords:Cerebral malaria   Indoleamine 2,3-dioxygenase   Kynurenic acid   Kynurenine pathway   Picolinic acid   Quinolinic acid   Tryptophan metabolism
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号